A case of complete remission of advanced hepatocellular carcinoma with type III portal vein tumor thrombosis treated using transarterial chemoembolization with microspheres and radiation therapy

被引:1
作者
Fukushima, Daizo [1 ]
Imai, Shigeki [2 ]
Nishino, Noriyuki [1 ]
Hamada, Kohichi [3 ]
Horikawa, Yoshinori [1 ]
Shiwa, Yoshiki [1 ]
Nishida, Shinya [1 ]
Koyanagi, Ryota [3 ]
Wada, Hitoshi [4 ]
Sakuma, Hideo [5 ]
机构
[1] Southern Tohoku Gen Hosp, Dept Gastroenterol, 7-115 Yatsuyamada, Koriyama, Fukushima 9638563, Japan
[2] Southern Tohoku Res Inst Neurosci, Dept Radiol, 7-115 Yatsuyamada, Koriyama, Fukushima 9638563, Japan
[3] Fukushima Med Univ, Dept Minimally Invas Surg & Med Oncol, Fukushima 9601295, Japan
[4] Southern Tohoku Proton Therapy Ctr, Dept Radiat Oncol, 7-172 Yatsuyamada, Koriyama, Fukushima 9638052, Japan
[5] Southern Tohoku Res Inst Neurosci, Dept Pathol, 7-115 Yatsuyamada, Koriyama, Fukushima 9638563, Japan
关键词
Hepatocellular carcinoma; Portal vein tumor thrombosis; Arterio-portal shunt; Transarterial chemoembolization; Radiation therapy; DRUG-ELUTING BEADS; ARTERIOPORTAL SHUNT; EFFICACY; SAFETY;
D O I
10.1007/s12328-020-01124-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Portal vein tumor thrombosis (PVTT) is an extremely locally advanced form of hepatocellular carcinoma. The natural median survival time of patients with hepatocellular carcinoma with PVTT is 2.7 to 4.0 months. A 63-year-old woman visited our clinic complaining of abdominal distention and appetite loss, which she had had for 3 weeks prior to admission. A contrast-enhanced computed tomography scan showed double hepatocellular carcinomas with Type III PVTT and massive ascites caused by arterio-portal shunts within the PVTT. The ascites could not be treated by concentrated ascites reinfusion therapy or diuretics. Transarterial embolization using microspheres followed by radiation therapy against PVTT and five courses of transarterial chemoembolization using microspheres and cisplatin led to the maintaining of complete remission of both ascites and tumors for over 12 months after treatment. Fluoroglucose accumulation of PVTT showed 11.2 as a maximum standard uptake value on positron emission tomography before treatment. No fluoroglucose accumulation within PVTT was observed for over 12 months following treatment. Transarterial chemoembolization using microspheres followed by radiation therapy against Type III PVTT may result in drastic anti-cancer effects and improvement of both serum albumin and intractable ascites after treatment of arterio-portal shunts within the PVTT causing portal hypertension.
引用
收藏
页码:847 / 854
页数:8
相关论文
共 50 条
[21]   Stereotactic body radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis [J].
Kang, Jingbo ;
Nie, Qing ;
Du, Rui ;
Zhang, Liping ;
Zhang, Jun ;
Li, Qiliang ;
Li, Jianguo ;
Qi, Wenjie .
MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (01) :43-50
[22]   Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative Study [J].
Jun Luo ;
Rong-Ping Guo ;
Eric C. H. Lai ;
Yao-Jun Zhang ;
Wan Yee Lau ;
Min-Shan Chen ;
Ming Shi .
Annals of Surgical Oncology, 2011, 18 :413-420
[23]   Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative Study [J].
Luo, Jun ;
Guo, Rong-Ping ;
Lai, Eric C. H. ;
Zhang, Yao-Jun ;
Lau, Wan Yee ;
Chen, Min-Shan ;
Shi, Ming .
ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (02) :413-420
[24]   Is hepatic resection better than transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis? [J].
Ibrahim, Canine ;
Parra, Natalia ;
Macedo, Francisco Igor ;
Yakoub, Danny .
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 10 (06) :1064-1072
[25]   Radiation Therapy for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis [J].
Park, Seung Gyu ;
Kim, Jin Hee ;
Byun, Sang Jun ;
Kim, Ok Bae ;
Hwang, Jae Seok ;
Oh, Young Kee ;
Choi, Tae Jin .
RADIATION ONCOLOGY JOURNAL, 2011, 29 (01) :36-43
[26]   Immune-Targeted Therapy with or without Transarterial Chemoembolization (TACE) for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis (PVTT): A Multicenter Retrospective Study [J].
You, Ran ;
Cheng, Yuan ;
Diao, Lingfeng ;
Wang, Chendong ;
Leng, Bin ;
Yu, Zeyu ;
Xu, Qingyu ;
Yin, Guowen .
BIOMEDICINES, 2024, 12 (09)
[27]   Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus [J].
Zheng, Ninggang ;
Wei, Xiaodong ;
Zhang, Dongzhi ;
Chai, Wenxiao ;
Che, Ming ;
Wang, Jiangye ;
Du, Binbin .
MEDICINE, 2016, 95 (26)
[28]   Efficacy of transarterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis [J].
Leng, Jian-Jun ;
Xu, Yin-Zhe ;
Dong, Jia-Hong .
ANZ JOURNAL OF SURGERY, 2016, 86 (10) :816-820
[29]   Efficacy of transarterial chemoembolization-hepatic arterial infusion chemotherapy combined with targeted therapy and immunotherapy in hepatocellular carcinoma with portal vein tumor thrombosis [J].
Hou, Xunbo ;
Xu, Qiannan ;
Yin, Linan ;
Wang, Huiwen ;
Wu, Juan ;
Liu, Bowen ;
He, Dongfeng ;
Liu, Ruibao .
ONCOLOGY LETTERS, 2025, 30 (01)
[30]   Outcome of transarterial chemoembolization in Egyptian patients with hepatocellular carcinoma and branch portal vein thrombosis [J].
Abdella H. ;
Shaker M.K. ;
Montasser I.F. ;
Sobhi M. ;
Aly H. ;
Sayed A. ;
Saleh S. ;
El Dorry A. .
Indian Journal of Gastroenterology, 2018, 37 (2) :127-132